Navigation Links
Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
Date:11/18/2008

o 19 in Washington, DC. Each year SfN provides the premier venue for neuroscientists to share research findings. SfN's annual meeting draws diverse attendees from all over the world.

About NeuroDiscovery

NeuroDiscovery Ltd is an ASX listed speciality neuroscience services provider and drug development company which owns 100% of NeuroSolutions Ltd (ASX Code NDL).

About NeuroSolutions

NeuroSolutions Limited is a profitable service company, which has applied its broad spectrum expertise and drug discovery platforms to become a leading provider of specialised electrophysiological assays to the biopharmaceutical industry. Electrophysiology is a specialised technique which is used to record electrical activity in membranes, cells or tissues. NeuroSolutions' current clients include many established pharmaceutical and biotechnology companies.

In parallel to running its service business, the Company is also exploiting its in-house technologies and expertise for its own internal R&D and has a mature pipeline of programmes underway for the treatment of pain.

During 2008, the Company reported success in a Phase II trial for NSL-101. The Company also successfully completed two Phase I trials for the development compound NSL-043/SD118, in partnership with Sosei Co. Ltd. Both of these trials reported a successful outcome, facilitating further development.

About Sosei

Sosei Group is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan.

For further information about Sosei, please visit

SOURCE Sosei Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sosei Announces Completion of Phase III Trial for NorLevo(R)
2. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
3. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
4. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
5. Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
6. Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
7. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
8. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
9. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
10. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
11. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Breathe , the fastest growing online sleep apnea shopping destination ... received more than 4.5 million unique page views since the start ... many people are finding our blog and reading our articles," said ... making sleep apnea more widely known and hope that people continue ... news , troubleshooting advice , and new product launches ...
(Date:8/20/2014)... , Aug. 20, 2014  Quantum Materials ... diverse sets of patent families from Bayer Technology Services ... driver for Bayer AG of Leverkusen, ... acquired provide broad intellectual property protection for advances ... high-volume quantum dot (QD) manufacturing. In addition, the ...
(Date:8/19/2014)... BIRMINGHAM, Ala. , Aug. 19, 2014  The Alabama ... re-affirmed that patients can sue drug makers who mislead doctors ... cause harmful side‑effects.  The case is Weeks v. Wyeth, and ... drug makers in that same case last year. Heninger Garrison ... represent the patient in the case, Danny Weeks ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4
... The Food and Drug Administration (FDA) has recently issued ... a "natural sexual enhancer" that contains a hidden drug ... because of a label mix-up an infusion set that ... for pregnant women (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ...
... A state-of-the-art, eFlow Technology nebulizer (PARI Pharma GmbH) has ... (Mee-us), a 27-year-old orangutan, has what veterinarians believe to ... a substantial problem in both wild and zoo orangutans. ... also have some similarities to cystic fibrosis in people. ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: March 2011 2Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 2Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 3Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 4
(Date:8/20/2014)... 2014 Transrectal ultrasound guided biopsy is the gold ... suggested that the number of risks associated with the ... Swedish researchers found that six percent of men filled ... within 30 days after having a prostate biopsy, with ... reports The Journal of Urology . , Earlier ...
(Date:8/20/2014)... Rockville Centre, NY (PRWEB) August 20, 2014 ... Martinotti and filed on August 7 in the multicounty ... New Jersey (IN RE DEPUY ASR HIP IMPLANTS LITIGATION; ... in the MCL have been dismissed without prejudice. The ... “in the process of being resolved.” The Rottenstein Law ...
(Date:8/20/2014)... IQ Formulations , a top national health and ... 500 , distinguishing it as one of the fastest growing ... made the list, but was ranked in the top 50 ... years. It also ranked ninth among all health companies, fifth ... fastest growing company in the Miami metro area. , ...
(Date:8/20/2014)... 2014 The finalists are in for ... industry trade magazine, will honor the pharmaceutical industry’s most ... given to outstanding companies, marketers and brand managers representing ... “We are proud to announce that we received our ... double the number of submissions we received last year,” ...
(Date:8/20/2014)... A Missouri federal judge has remanded a lawsuit ... with GranuFlo and NaturaLyte to the City of St. Louis ... Budd. The judge rejected an assertion by the defendants that ... (McGee, et al. v. Fresenius Medical Care North America Inc., ... is the manufacturer of the dialysis products GranuFlo and NaturaLyte. ...
Breaking Medicine News(10 mins):Health News:Severe infections with hospitalization after prostate biopsy rising in Sweden 2Health News:350 NJ DePuy ASR Lawsuits Dismissed Pending Settlement Talks, Notes Rottenstein Law Group LLP 2Health News:Leading Health Supplement Company IQ Formulations Among Inc. Magazine’s Top 50 Fastest Growing Private Companies in the United States 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 4Health News:PM360 Announces 2014 Trailblazer Award Finalists 5Health News:PM360 Announces 2014 Trailblazer Award Finalists 6Health News:PM360 Announces 2014 Trailblazer Award Finalists 7Health News:PM360 Announces 2014 Trailblazer Award Finalists 8Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2
... President, Congress to Include Plan in Broader Health ... now exists for the Obama Administration and Congress ... well as save approximately $35 billion over ten ... long term care reform plan, the nation,s leading ...
... Study examines why people suffer mood disorder after discharge ... that predict depression in people after they,ve been hospitalized ... Johns Hopkins researchers. , Their study involved 160 people ... distress syndrome that typically requires invasive interventions, including the ...
... Co-located Events Provide One Stop Business Forum for Beauty ... The entire product development life cycle will be on ... Global Expo and the Spa & Resort/Medical Aesthetics Expo ... opportunities. HBA Global Expo will take place September ...
... that the traditional risk factors for melanoma may not be ... thought, according to data presented at the American Association for ... clinician might look at a person with dark hair who ... for melanoma, but that may not be true for all ...
... 3000 - the latest series of wall-mounted diagnostic imaging ... Ill., April 21 MAXANT Technologies, a leader in ... the MediPort 3000, the latest innovation in its line ... of a view box, the MediPort created a new ...
... and summer weekend fun ahead in Gladstone GLADSTONE, Mich., April ... teaming up with several area groups and businesses to sponsor a ... first annual "Da, U.P. Ride for the Red" on motorcycles. ... 17, local food vendors will offer their fares. Beer and soda ...
Cached Medicine News:Health News:Avalere Health Finds New Plan to Reform Medicare Post-Acute and Long Term Care System Could Save U.S. Approximately $35 Billion Over Ten Years 2Health News:Avalere Health Finds New Plan to Reform Medicare Post-Acute and Long Term Care System Could Save U.S. Approximately $35 Billion Over Ten Years 3Health News:Avalere Health Finds New Plan to Reform Medicare Post-Acute and Long Term Care System Could Save U.S. Approximately $35 Billion Over Ten Years 4Health News:Organ Failure, Sedative Use in ICU May Lead to Depression 2Health News:HBA Global Expo and Spa & Resort/Medical Aesthetics Expo to Offer Full Spectrum of the Product Development Cycle 2Health News:HBA Global Expo and Spa & Resort/Medical Aesthetics Expo to Offer Full Spectrum of the Product Development Cycle 3Health News:Dark hair? Don't burn? Your genes may still put you at risk for melanoma 2Health News:MAXANT Launches MediPort 3000, The Next-Generation of All-In-One Workstations, on Its Newly Designed Website 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: